Developing next-generation oligonucleotide therapeutics

preview_player
Показать описание
Oligonucleotide therapeutics offer tremendous potential to enable long-lasting treatment with a precision medicine approach.

Learn about how scientists with expertise in data science, chemistry, biology and physics accelerate the design-make-test-analyse (DMTA) cycle of drug discovery to ensure these therapies are optimised for efficacy and safety.

------------------------------------------------------------

Follow us:
Рекомендации по теме